von Stefanie Simons | Okt 2, 2019
DGN Kongress - Stuttgart September 26th, 2019 Learn more Prof. Dieter Willbold participated at the DGN Kongress in Stuttgart.He gave a talk on the 26th September at 09.10 am.Content: Targeting Alzheimer´s disease with the first anti-prionic compound: PRI-002 proved...
von Stefanie Simons | Jul 5, 2019
AAIC - Los Angeles July 14th – 18th, 2019 Learn more Priavoid will participate at the AAIC 2019 in Los Angeles. News & Events: AAIC 2019 Keystone Symposium Neuro4D Conference Seed Investment CEOs of Priavoid AD/PD 2019 – Lisbon BioRiver Boost! 2018 The...
von Stefanie Simons | Jun 3, 2019
Keystone Symposium June 18th, 2019 – Keystone, CO, USA Learn more Dieter Willbold will present PRI-002 at the Keystone Symposium “Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2) in Keystone, CO, USA. News & Events: AAIC 2019...
von Dagmar jürgens | Mai 6, 2019
Neuro4D Conference 2019 May 14th – 15th, 2019 – Mainz, Germany Learn more May 13th, 2019: Dieter Willbold will present PRI-002 at the Neuro4D Confernce in Mainz, Germany. May 14th, 2019: Antje Willuweit will present PRI-003 at the Neuro4D Conference in...
von Dagmar jürgens | Mai 6, 2019
Seed Investment March 28th, 2019 Priavoid obtained seed investment. News & Events: AAIC 2019 Keystone Symposium Neuro4D Conference Seed Investment CEOs of Priavoid AD/PD 2019 – Lisbon BioRiver Boost! 2018 The Nobel Prize Prof. Willbold´s interview with...
Neue Kommentare